310 results on '"Chantarangkul V"'
Search Results
2. Variability of cut‐off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study
Catalog
Books, media, physical & digital resources
3. Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme
4. Thrombin Generation Assay (TGA) for Testing of Haemostatic Effectiveness of Factor VIII (FVIII) Concentrates in Patients with Hemophilia A and Inhibitors: In Vitro Results from the Predictga Study: OR04
5. International Collaborative Study for the Calibration of a Proposed International Standard for thromboplastin, human, plain
6. Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile
7. Thromboplastin standards
8. Effect of prothrombin time outlier exclusion rules on ISI calibration in multicentre studies
9. Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy: comment
10. Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS‐13)
11. High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism
12. The international normalized ratio to prioritize patients for liver transplantation: problems and possible solutions
13. Failure of corn trypsin inhibitor to affect the thrombin generation assay in plasma from severe haemophiliacs: comment
14. Coagulation balance and liver damage in non-cirrhotic patients with chronic hepatitis C after eradication by Direct-acting Antiviral Agents (DAAs)
15. Evidence that low protein C is a crucial determinant of the pro-coagulant imbalance in cirrhosis: PB 4.51–1
16. Thrombin generation assay (TGA) is not able to predict hemostatic efficacy of by-passing agents in patients with hemophilia and inhibitors: results from in vivo studies: PA 4.11–6
17. Bypassing therapy in patients with hemophilia and inhibitors: In vivo studies of thrombin generation capacity: PO-TU-079
18. Comparison of thrombin generation for paired-platelet-rich plasma collected with and without corn trypsin inhibitor from hemophiliacs treated with factor-VIII inhibitor bypassing agents
19. Discrepancy of the international normalized ratio observed in the external quality assessment survey: a cause for concern
20. More on: enhanced thrombin generation in patients with cirrhosis-induced coagulopathy
21. The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro study
22. Procoagulant imbalance in patients with non-cirrhotic Chronic hepatitis C (CHC) improves six months after eradication with direct-acting antiviral agents (DAAs) and likely correlates with liver fibrosis
23. More on: new antithrombotics: a need for laboratory monitoring. For or against
24. Corn trypsin inhibitor (CTI) for thrombin generation (TG) assays: to add or not to add: 09P10
25. More on: high thrombin generation and the risk of recurrent venous thromboembolism
26. Performance of quantitative D-dimer methods: results of the Italian external quality assessment scheme
27. Activated partial thromboplastin time: results of a case–control study evaluating six commercial reagents in assessing the risk of venous thromboembolism
28. International collaborative study for the calibration of a proposed international standard for thromboplastin, rabbit, plain
29. Endogenous thrombin potential (ETP) in severe hemophiliacs with mild phenotype: 06 PO 183
30. Measurement of von Willebrand factor cleaving protease (ADAMTS‐13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas
31. Procoagulant imbalance in chronic hepatitis C and its relationship with cardiovascular and liver damage
32. Effect of Tamoxifen on Measurements of Hemostasis in Healthy Women
33. International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain
34. Thrombin generation assay (TGA) for testing haemostatic response in patients with Hemophilia A and inhibitors on immune tolerance induction treatment (ITI): Preliminary in vivo results from the PredicTGA study
35. Impact of von Willebrand factor and ADAMTS-13 on the pro-coagulant imbalance of patients with cirrhosis
36. Impact of von Willebrand factor/ADAMTS-13 on the pro-coagulant imbalance detected in cirrhosis
37. Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agents
38. The thrombin generation assay distinguishes inhibitor from non‐inhibitor patients with severe haemophilia A
39. Increased plasma levels of Von Willebrand factor (VWF) and Factor VIII (FVIII) during acute bacterial infection drive a pro-hemostatic imbalance and herald severe outcome in cirrhosis
40. Increased Plasma Levels of Von Willebrand Factor and Factor VIII (FVIII) During Acute Bacterial Infection Drive a Pro-Hemostatic Imbalance and Herald Severe Outcome in Cirrhosis
41. Increased thrombin generation in inflammatory bowel disease
42. Anti phospholipid antibody ELISAs: Survey on the performance of clinical laboratories assessed by using lyophilized affinity-purifled IgG with anticardiolipin and anti-beta 2-glycoprotein I activity
43. Hemo Web, a web-based tool to handel the external quality control program for the hemophilia center coagulation laboratory
44. SAT-063 - Impact of von Willebrand factor/ADAMTS-13 on the pro-coagulant imbalance detected in cirrhosis
45. P464 RESISTANCE TO THROMBOMODULIN IS ASSOCIATED WITH DE NOVO PORTAL VEIN THROMBOSIS AND COULD BE A MODIFIABLE FACTOR TO IMPROVE PROGNOSIS IN PATIENTS WITH CIRRHOSIS
46. Resistance to thrombomodulin is associated with de novo portal vein thrombosis and could be a modifiable factor to improve prognosis in cirrhosis
47. THU-399 - Increased Plasma Levels of Von Willebrand Factor and Factor VIII (FVIII) During Acute Bacterial Infection Drive a Pro-Hemostatic Imbalance and Herald Severe Outcome in Cirrhosis
48. MANAGEMENT OF HEMOSTASIS ABNORMALITIES IN CIRRHOSIS: FROM BENCH TO BEDSIDE.
49. Residual platelets are the main determinants of microparticles count in frozen-thawed plasma
50. Standardization of lupus anticoagulant. The Lupus Anticoagulant Sensitivity Index (LASI)
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.